| Financial Year |
March 31 2022 |
| Monetary Funds |
127,749,309.73 |
| Held-for-trading Financial Assets |
996,921.68 |
| Notes Receivable |
-- |
| Accounts Receivable |
195,950,667.87 |
| Advances to Suppliers |
11,298,133.15 |
| Other Receivables |
222,244,357.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,063,782.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
229,336,498.99 |
| Other Current Assets |
34,822,055.77 |
| Total Current Assets |
876,461,726.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
98,086,909.18 |
| Long-term Equity Investment |
224,293,848.09 |
| Investment Properties |
4,070,564.56 |
| Fixed Assetes |
84,056,647.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,971,924.70 |
| R&D expenses |
-- |
| Goodwill |
4,814,258.43 |
| Long-Term Deferred and Prepaid Expenses |
376,709.36 |
| Deferred Income Tax Assets |
23,766.32 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,206,353,922.53 |
| Total Assets |
2,082,815,649.45 |
| Short-Term Loans |
859,661,198.04 |
| Trading Financial liabilities |
423,333,333.33 |
| Notes Payable |
-- |
| Accounts Payable |
382,437,143.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,835,299.25 |
| Taxes Payable |
301,496,468.13 |
| Interest Payable |
184,153,509.80 |
| Dividend Payable |
-- |
| Other payables |
755,079,182.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
242,907,923.51 |
| Other Current Liabilities |
180,156,762.00 |
| Sub-Total of Current Liabilities |
3,242,160,090.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
439,859,102.45 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
442,915,398.57 |
| Total Liabilities |
3,685,075,489.24 |
| Paid-In Capital(Or Share Stock) |
1,195,772,516.00 |
| Capital Surplus |
1,272,474,718.62 |
| Surplus Reserve |
137,451,276.63 |
| LESS:Treasury Stock |
15,592,261.38 |
| Undistributed Profits |
-4,193,268,029.62 |
| Minority Stockholder's Interest |
12,711,261.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,614,971,101.42 |
| Owner's Equity（Stockholder's Equity） |
-1,602,259,839.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,082,815,649.45 |
